Saturday 17 October 2026 Export PTCT’s income statement to Excel — free account

PTC Therapeutics, Inc.

PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024. In the quarter to June 2026, revenue grew 101.6%, EPS grew 221.7%, free cash flow grew 295.7% and total debt rose 21.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

59.24 1.75 −2.87%

Follow PTCT

Alert me

Market cap: $5.1B
P/E: 0.0×
Fwd P/E: 110×
Dividend yield: —
F-score: 7/9
Altman Z: 1.86
Beneish M: −1.48
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	6.39	8.64	0.00	0.00
P/S ratio Full definition →		2.71	3.49	6.80	6.71
P/FCF ratio Full definition →		10.79	13.62	0.00	0.00
P/Operating CF Full definition →		(72.63)	(176.27)	(95.22)	52.44
P/B ratio Full definition →		0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		3.10	3.87	7.67	7.39
EV/EBITDA Full definition →		5.78	7.53	0.00	45.79
EV/Operating CF Full definition →		7.70	9.41	(29.11)	(244.38)
EV/FCF Full definition →		12.35	15.10	(13.14)	(24.83)
Quick Ratio Full definition →		2.18	2.20	2.29	3.20
Current Ratio Full definition →		2.32	2.35	2.44	3.39
Net Debt/EBITDA Full definition →		83.37	(10.33)	12.55	4.27
Debt/Assets Full definition →		90.10%	89.62%	91.11%	89.60%
Debt/Equity Full definition →		(15.29)	(12.65)	(14.49)	(17.61)
Asset Turnover Full definition →		0.79	0.75	0.30	0.34
Operating CF/Net income Full definition →		(4.17)	0.25	21.02	1.55
Capex/Depreciation Full definition →		(48.24)	(0.29)	(0.11)	(0.64)
Interest Coverage Full definition →		0.09	(1.29)	0.92	3.07
Research and Development Expense of Revenue Full definition →		47.47%	80.84%	37.01%	27.50%
Selling, General and Administrative Expense of Revenue Full definition →		39.83%	58.83%	31.62%	22.36%
Intangible Assets out of Total Assets Full definition →		0.18	0.16	0.16	0.15
Share Based Compensation of Revenue Full definition →		9.21%	11.25%	8.59%	6.46%
Graham Net Nets Full definition →		(0.16)	(0.14)	(0.14)	(0.12)
Graham Number Full definition →		0.00	0.00	10.71	4.69
Earnings Yield Full definition →		15.66%	11.57%	(3.42%)	(0.60%)
Free Cash Flow Yield Full definition →		9.27%	7.34%	(8.59%)	(4.43%)
Revenue per Share Full definition →		2.69	2.07	3.30	4.34
Operating CF per Share Full definition →		(0.84)	(0.43)	(0.72)	1.56
Capex per Share Full definition →		(3.26)	(0.03)	(0.02)	(0.09)
Free Cash Flow per Share Full definition →		(4.11)	(0.46)	(0.73)	1.47
Cash per Share Full definition →		21.51	24.46	22.93	26.85
Shareholders Equity per Share Full definition →		(1.98)	(2.58)	(2.19)	(1.99)
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(1.98)	(2.58)	(2.19)	(1.99)
Free Cash Flow Full definition →		(322.50)	(36.65)	(60.39)	121.97
Working Capital Full definition →		1,141.56	1,305.52	1,330.40	1,846.29
Capital Expenditures Full definition →		(256.19)	(2.37)	(1.35)	(7.14)
Net Current Asset Value Full definition →		(791.65)	(830.13)	(795.57)	(798.48)
EV/EBIT Full definition →		7.10	7.72	0.00	59.35
Capex to Sales Full definition →		1.21	0.01	0.01	0.02
Price to Operating Income Full definition →		6.21	6.97	0.00	53.91
Other line items
Average Receivables Full definition →		201.53	170.09	215.21	217.59
Average Payables Full definition →		319.74	342.78	315.43	360.60
Average Inventory Full definition →		44.18	51.42	48.62	62.71
Average Assets Full definition →		2,242.97	2,301.90	2,762.25	2,942.32
Average Common Equity Full definition →		(605.05)	(651.69)	(183.11)	(185.95)

Fold the line items

Columns are period end dates

Stockrow Weekly